GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (NYSE:RMD) » Definitions » Forward Dividend Yield %
中文

ResMed (ResMed) Forward Dividend Yield %

: 1.04% (As of Today)
View and export this data going back to 1995. Start your Free Trial

As of today (2024-04-24), the Forward Annual Dividend Yield of ResMed is 1.04%.

As of today (2024-04-24), the Trailing Annual Dividend Yield of ResMed is 1.02%.

RMD's Forward Dividend Yield % is ranked worse than
73.4% of 312 companies
in the Medical Devices & Instruments industry
Industry Median: 1.98 vs RMD: 1.04

ResMed's Dividends per Share for the three months ended in Dec. 2023 was $0.48.

During the past 12 months, ResMed's average Dividends Per Share Growth Rate was 7.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 4.50% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 8.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of ResMed was 20.80% per year. The lowest was 3.70% per year. And the median was 6.45% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed Forward Dividend Yield % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ResMed's Forward Dividend Yield % falls into.



ResMed Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

ResMed Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.4802024-02-072024-02-082024-03-14Cash DividendquarterlyUSD:USD 1.000000
USD 0.4802023-11-082023-11-092023-12-14Cash DividendquarterlyUSD:USD 1.000000
USD 0.4802023-08-162023-08-172023-09-21Cash DividendquarterlyUSD:USD 1.000000
USD 0.4402023-05-102023-05-112023-06-15Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

ResMed's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=1.92/183.97
=1.04 %

Current Share Price is $183.97.
ResMed's Dividends per Share for the forward twelve months is calculated as $0.48 * 4 = $1.92.

ResMed's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=1.88/183.97
=1.02 %

Current Share Price is $183.97.
ResMed's Dividends per Share for the trailing twelve months (TTM) ended in Today is $1.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ResMed  (NYSE:RMD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


ResMed Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of ResMed's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed (ResMed) Business Description

Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Executives
Brett Sandercock officer: Chief Financial Officer 17 GUINEVIERE COURT, CASTLE HILL, NEW SOUTH WALES C3 2154
Michael J. Farrell officer: Chief Executive Officer C/O REMED INC, 9001 SPECTRUM CTR. BLVD., SAN DIEGO, CA 92123
Michael J Rider officer: Global General Counsel 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Robert Andrew Douglas officer: President and COO 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106
Kaushik Ghoshal officer: President, SaaS Business 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
David Pendarvis officer: Chief Administration Officer REDMED INC, 14040 DANLELSON ST, POWAY CA 92064
Karen Drexler director C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Justin Leong officer: President, Asia and LATAM C/O RESMED INC, 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Desney Tan director 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
John Hernandez director 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123
Lucile Blaise officer: President, Sleep & RC Business RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123
Peter C Farrell director RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857
James Hollingshead officer: President, Sleep Business C/O RESMED INC., 9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO CA 92123
Carol Burt director C/O WELLCARE HEALTH PLANS, INC., 8725 HENDERSON ROAD, TAMPA FL 33634
Resmed Inc director 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123